Nucleic acid aptamers as tools and drugs: recent developments.
Nucleic acid aptamers are molecules that bind to their ligands with high affinity and specificity. Unlike other functional nucleic acids such as antisense oligonucleotides, ribozymes, or siRNAs, aptamers almost never exert their effects on the genetic level. They manipulate their target molecules such as gene products or epitopes directly and site specifically, leaving nontargeted protein functions intact. In a similar way to antibodies, aptamers bind to many different kinds of target molecules with high specificity and can be made to order, but as a result of their different biochemical nature and size they can also be used complementary to antibodies. In some cases, aptamers might be more suitable or more specific than antibody approaches or small molecules, both as scientific and biotechnological tools and as therapeutic agents. Recent examples of characterization of aptamers as tools for scientific research to study regulatory circuits, as tools in diagnostic or biosensor development, and as therapeutic agents are discussed.
Rimmele
Martina
M
Research & Development, RiNA Netzwerk RNA Technologien GmbH, Takustrasse 3, 14195 Berlin, Germany. rimmele@rna-network.com
D000906:Antibodies / Q000737:chemistry / Q000627:therapeutic use; D001665:Binding Sites; D015374:Biosensing Techniques / Q000295:instrumentation / Q000379:methods; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems / Q000639:trends*; D015316:Genetic Therapy; D008024:Ligands; D008958:Models, Molecular; D009696:Nucleic Acids / Q000737:chemistry* / Q000627:therapeutic use*; D009841:Oligonucleotides / Q000737:chemistry* / Q000627:therapeutic use*; D013678:Technology, Pharmaceutical / Q000639:trends*
D000906:Antibodies; D008024:Ligands; D009696:Nucleic Acids; D009841:Oligonucleotides